SMi’s 4th Annual Pharmaceutical Microbiology East Coast Conference

Event Information

Sponsored by Microcoat

Chaired by Lynne Ensor, Vice President, RCS Head of Global Compliance, Parexel

Exploring Agile Contamination Control Strategy 

Biologic products require diligent microbial control because of their complex and sometimes growth-promoting manufacturing processes, and high-risk patient populations. The increase in complexity of pharmaceutical products, rise in development of biologics and increasingly stringent regulations for biologics are some of the factors that are driving the growth of the pharmaceutical microbiology market for biopharmaceutical products.

SMi Group invite all microbiologists to join the virtual conference to discuss Contamination Control Strategies, Effective Environmental Monitoring, and the newest schools of thought in personnel operation. Leaders in regulation and compliance will provide expert viewpoints on how to implement and interpret the regulation, in addition,  Annex 1 will be assessed and debated.